MARKET

COCP

COCP

COCRYSTAL PHARMA
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.320
-0.080
-5.71%
After Hours: 1.310 -0.01 -0.76% 19:59 05/07 EDT
OPEN
1.380
PREV CLOSE
1.400
HIGH
1.400
LOW
1.300
VOLUME
20.64M
TURNOVER
--
52 WEEK HIGH
3.460
52 WEEK LOW
0.7600
MARKET CAP
94.34M
P/E (TTM)
-7.2250
1D
5D
1M
3M
1Y
5Y
Insider Sale at Cocrystal Pharma (COCP) Deemed Significant
MT Newswires · 1d ago
BRIEF-Cocrystal Pharma Announces Closing Of $40 Mln Bought Deal
reuters.com · 1d ago
Cocrystal Pharma Announces Closing of $40 Million Bought Deal
BOTHELL, Wash., May 07, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of ...
GlobeNewswire · 1d ago
Cocrystal Pharma Raises $40 Million from Public Offering
MT Newswires · 2d ago
Insider Trends: Insider 90-Day Selling Trend Extended at Cocrystal Pharma
MT Newswires · 2d ago
Thinking about buying stock in Stealth BioTherapeutics, Rocket Comp, Cocrystal Pharma, AMC Entertainment, or Nokia?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MITO, RKT, COCP, AMC, and NOK.
PR Newswire - PRF · 3d ago
8-K: Cocrystal Pharma, Inc.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT (EDGAR Online via COMTEX) -- Pursuant to Section 13 or 15(d)...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 3d ago
Mid-Afternoon Market Update: Dow Surges 180 Points; Big 5 Sporting Goods Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded up 0.53% to 34,313.88 while the NASDAQ rose 0.18% to 13,658.26. The S&P also rose, gaining 0.41% to 4,181.69.
Benzinga · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of COCP. Analyze the recent business situations of COCRYSTAL PHARMA through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average COCP stock price target is 4.500 with a high estimate of 5.00 and a low estimate of 4.000.
EPS
Institutional Holdings
Institutions: 42
Institutional Holdings: 10.18M
% Owned: 14.25%
Shares Outstanding: 71.47M
TypeInstitutionsShares
Increased
6
979.76K
New
12
1.25M
Decreased
7
2.13M
Sold Out
5
2.74M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.86%
Pharmaceuticals & Medical Research
+1.04%
Key Executives
Chairman/Chief Executive Officer/Director
Gary Wilcox
President
Sam Lee
Chief Financial Officer
James Martin
Director
Roger Kornberg
Independent Director
Phillip Frost
Independent Director
Anthony Japour
Independent Director
Steven Rubin
No Data
About COCP
Cocrystal Pharma, Inc., is a clinical stage biotechnology company. The Company focuses on discovering and developing novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. The Company focuses on developing and commercializing antiviral drug candidates for the treatment and prophylaxis of hepatitis C, influenza and norovirus. The Company uses computational methods to screen and design product candidates using its cocrystal structural information. The Company’s Hepatitis C Virus (HCV) Non-Nucleoside Polymerase Inhibitor CC-31244 is a pan-genotypic inhibitor of NS5B polymerase for the treatment of hepatitis C infection. The Company’s CC-42344 is a novel PB2 inhibitor for the treatment of influenza infection. The Company is also focused on identifying and developing nucleoside and non-nucleoside polymerase inhibitors for the treatment of Norovirus infections.

Webull offers kinds of Cocrystal Pharma Inc stock information, including NASDAQ:COCP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COCP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading COCP stock methods without spending real money on the virtual paper trading platform.